About Technology Issues FAQ

exaly › Authors › Paul B Yu › discipline-rankings

Paul B Yu

Brigham and Women's Hospital

92(top 5%)

papers

7.2K(top 2%)

citations

43(top 2%)

h-index

86(top 2%)

g-index

118

all documents

7.9K

doc citations

1.4K

citing journals

105

times ranked

Filter by:Citations (per year) (7) | Most Cited Article (per year) (12) | Low Rankings (per year) (21) |

19^th most cited paper in Clinical Immunology (2001) [with 67 citations of an article]

24^th most cited paper in Organic Chemistry (2008) [with 315 citations of an article]

26^th most cited paper in Bioorganic chemistry (2008) [with 315 citations of an article]

34^th most cited paper in Thrombosis (2012) [with 188 citations of an article]

34^th most cited paper in vascular diseases (2012) [with 188 citations of an article]

35^th most cited paper in Growth factors (2009) [with 103 citations of an article]

36^th most cited author in Growth factors (2009) [with 103 citations of 1 articles]

42^nd most cited paper in Bones (2020) [with 80 citations of an article]

43^rd most cited author in Bioorganic chemistry (2008) [with 315 citations of 1 articles]

45^th most cited paper in Cytokine (2009) [with 103 citations of an article]

46^th most cited paper in Immunopathology (1997) [with 52 citations of an article]

47^th most cited author in Cytokine (2009) [with 103 citations of 1 articles]

49^th most cited author in vascular diseases (2012) [with 188 citations of 1 articles]

51^st most cited author in Organic Chemistry (2008) [with 315 citations of 1 articles]

56^th most cited author in Thrombosis (2012) [with 188 citations of 1 articles]

66^th most cited paper in Immunopathology (2001) [with 67 citations of an article]

82^nd most cited paper in cytokines (2009) [with 103 citations of an article]

87^th most cited author in cytokines (2009) [with 103 citations of 1 articles]

99^th most cited paper in Immunopathology (1999) [with 38 citations of an article]

site/software © exaly; All materials licenced under CC by-SA.